🔎 Trials Near Me

Inicio › Enfermedad de células falciformes › Georgia

Ensayos clínicos de Enfermedad de células falciformes en Georgia

25 estudios sobre Enfermedad de células falciformes buscan participantes en Georgia.

Ciudades en Georgia

Texto oficial del estudio (inglés)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Augusta University Georgia, Augusta
  • WCG Sonar Clinical Research, Riverdale
ReclutandoFase 3
Edades de 12 a 100 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • Emory University, Atlanta
  • Augusta University, Augusta
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Children's Healthcare Atlanta, Atlanta
ReclutandoFase 3
Edades de 2 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Children's Healthcare Atlanta, Atlanta
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06612268

Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing

  • Children's Healthcare of Atlanta, Atlanta
Reclutando
Edades de 8 a 18 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07562451

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • Children's Center for Advanced Pediatrics, Atlanta
ReclutandoFase 2/3
Edades de 12 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT05431088

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Winship Cancer Institute of Emory University, Atlanta
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
  • Emory/Children's Health Care of Atlanta, Atlanta
  • Memorial Health University Medical Center, Savannah
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 17 ago 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 14 ago 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07224360

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
ReclutandoFase 1/2
Edades de 7 a 21 · Todos los sexos · Actualizado el 29 jul 2026 · NCT02447874

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Emory University School of Medicine, Atlanta
ReclutandoEstudio observacional
Edades de 4 a 65 · Todos los sexos · Actualizado el 27 jul 2026 · NCT05153967

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  • Augusta University Georgia, Augusta
ReclutandoFase 4
6 Months – 100 Years · Todos los sexos · Actualizado el 8 jun 2026 · NCT04657822

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Children's Healthcare of Atlanta (MRD-HCT), Atlanta
ReclutandoEstudio observacional
Edades de 3 a 20 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06941389

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

  • Children's Healthcare of Atlanta, Atlanta
ReclutandoFase 1/2
Edades de 12 a 45 · Todos los sexos · Actualizado el 4 jun 2026 · NCT07252050

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

  • Emory University, Atlanta
ReclutandoFase 4
Edades de 18 a 50 · Mujeres · Actualizado el 28 may 2026 · NCT06665997

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

  • Children's Healthcare of Atlanta, Atlanta
Reclutando
Edades de 13 a 21 · Todos los sexos · Actualizado el 11 may 2026 · NCT06290401

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

  • Site # 8400006, Atlanta
  • Site # 8400002, Atlanta
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 15 abr 2026 · NCT07247188

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

  • Grady Health System, Atlanta
ReclutandoFase 4Se aceptan voluntarios sanos
Edades de 18 en adelante · Mujeres · Actualizado el 18 feb 2026 · NCT06979492

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Children's Healthcare of Atlanta - Aflac Cancer and Blood Disorders Center- Egleston, Atlanta
ReclutandoEstudio observacional
Edades de 14 a 37 · Todos los sexos · Actualizado el 28 ene 2026 · NCT07373639

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

  • Children's Hospital of Atlanta: Eagelston, Atlanta
Reclutando
Edades de 7 a 18 · Todos los sexos · Actualizado el 26 ene 2026 · NCT07090668

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • Augusta University, Augusta
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 ene 2026 · NCT01245179

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • Children's Healthcare of Atlanta, Atlanta
Reclutando
Edades de 16 a 30 · Todos los sexos · Actualizado el 7 ene 2026 · NCT06374238

Integrative Training Program for Pediatric Sickle Cell Pain

  • Children's Healthcare of Atlanta, Atlanta
  • Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
Reclutando
Edades de 12 a 18 · Todos los sexos · Actualizado el 14 nov 2025 · NCT06691867

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • Augusta University, Augusta
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jun 2025 · NCT06385886

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.